Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Neoplasms × binimetinib × Clear all

Phase

Phase 1 4 Phase 2 3 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 4 Skin Neoplasms 3 Skin Diseases 2 Neoplasm Metastasis 2 Neoplasms 1 Low-grade Serous Ovarian Cancer 1 Colorectal Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Fluorouracil 117 Leucovorin 110 Oxaliplatin 84 Bevacizumab 74 Irinotecan 66 Capecitabine 58 Cetuximab 37 Folfox protocol 30 Panitumumab 16 regorafenib 13 Drug Therapy 13 trifluridine tipiracil drug combination 12 Chemotherapy, Adjuvant 11 IFL protocol 9 Radiotherapy 8 Floxuridine 8 Neoadjuvant Therapy 7 Aspirin 7 pembrolizumab 5 XELOX 5 Mitomycin 5 Levoleucovorin 5 Laparoscopy 5 dehydroftorafur 4 atezolizumab 4 Trifluridine 4 S 1 (combination) 4 Octreotide 4 Magnetic Resonance Spectroscopy 4 Levamisole 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02928224 2023-12-21

BEACON CRC

Pfizer

Phase 3 Completed

702 enrolled 82 charts 2 FDA

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡